Clinical trial
A randomized, double-blind, active-controlled, parallel group, 52-week study to evaluate the effect of LCZ696 compared to olmesartan on regional aortic stiffness in subjects with essential hypertension.
To evaluate the effect of LCZ696 as compared to olmesartan on aortic distensibility after 12 weeks of treatment in hypertensive subjects.
| Category | Value |
|---|---|
| Study start date | 2013-06-19 |